AIM: This study investigated insulin pump therapy in pediatric patients with type 1 diabetes and Turkish origin compared with those without migration background in Germany. SUBJECTS AND METHODS: Using a nationwide documentation program, we estimated the prevalence of insulin pump therapy in patients < 20 years of age with Turkish origin and those without migration background. Logistic regression was used to adjust for age, sex, diabetes duration, body mass index SD score (BMI-SDS), glycated hemoglobin, number of outpatient visits, number of daily blood glucose self-measurements, and area-based socioeconomic conditions. RESULTS: In 1,695 pediatric type 1 diabetes patients with Turkish background and 19,802 patients without migration background (respectively: 51.2% and 53.0% boys; mean age, 12.4 ± 4.1 and 12.6 ± 4.2 years; mean diabetes duration, 4.7 ± 3.9 and 5.3 ± 4.0 years), fully adjusted prevalences of insulin pump therapy were 18.5% and 30.9%, respectively (odds ratio 0.51, 95% confidence interval 0.43-0.60, P < 0.001). Age, sex, BMI-SDS, outpatient visits, and blood glucose self-control were significantly associated with the prevalence of insulin pump therapy but did not alter the difference substantially. CONCLUSIONS: The prevalence of insulin pump therapy is roughly half among pediatric diabetes patients with Turkish background compared with those without migration background. Several covariates could not explain this difference. Individual characteristics or access barriers within the healthcare system may play a role. Further research is needed.
AIM: This study investigated insulin pump therapy in pediatric patients with type 1 diabetes and Turkish origin compared with those without migration background in Germany. SUBJECTS AND METHODS: Using a nationwide documentation program, we estimated the prevalence of insulin pump therapy in patients < 20 years of age with Turkish origin and those without migration background. Logistic regression was used to adjust for age, sex, diabetes duration, body mass index SD score (BMI-SDS), glycated hemoglobin, number of outpatient visits, number of daily blood glucose self-measurements, and area-based socioeconomic conditions. RESULTS: In 1,695 pediatric type 1 diabetespatients with Turkish background and 19,802 patients without migration background (respectively: 51.2% and 53.0% boys; mean age, 12.4 ± 4.1 and 12.6 ± 4.2 years; mean diabetes duration, 4.7 ± 3.9 and 5.3 ± 4.0 years), fully adjusted prevalences of insulin pump therapy were 18.5% and 30.9%, respectively (odds ratio 0.51, 95% confidence interval 0.43-0.60, P < 0.001). Age, sex, BMI-SDS, outpatient visits, and blood glucose self-control were significantly associated with the prevalence of insulin pump therapy but did not alter the difference substantially. CONCLUSIONS: The prevalence of insulin pump therapy is roughly half among pediatric diabetespatients with Turkish background compared with those without migration background. Several covariates could not explain this difference. Individual characteristics or access barriers within the healthcare system may play a role. Further research is needed.
Authors: Thomas M Kapellen; Christoph Klinkert; Bettina Heidtmann; Bela Jakisch; Holger Haberland; Sabine E Hofer; Reinhard W Holl Journal: Postgrad Med Date: 2010-05 Impact factor: 3.840
Authors: Carine E de Beaufort; Peter G F Swift; Chas T Skinner; Henk J Aanstoot; Jan Aman; Fergus Cameron; Pedro Martul; Francesco Chiarelli; Dennis Daneman; Thomas Danne; Harry Dorchy; Hilary Hoey; Eero A Kaprio; Francine Kaufman; Mirjana Kocova; Henrik B Mortensen; Pal R Njølstad; Moshe Phillip; Kenneth J Robertson; Eugen J Schoenle; Tatsuhiko Urakami; Maurizio Vanelli Journal: Diabetes Care Date: 2007-05-31 Impact factor: 19.112
Authors: David M Maahs; Julia M Hermann; Stephanie N DuBose; Kellee M Miller; Bettina Heidtmann; Linda A DiMeglio; Birgit Rami-Merhar; Roy W Beck; Edith Schober; William V Tamborlane; Thomas M Kapellen; Reinhard W Holl Journal: Diabetologia Date: 2014-06-04 Impact factor: 10.122
Authors: Nicole Scheuing; Susanna Wiegand; Christina Bächle; Elke Fröhlich-Reiterer; Eva Hahn; Andrea Icks; Karl-Heinz Ludwig; Kirsten Mönkemöller; Oliver Razum; Joachim Rosenbauer; Reinhard W Holl Journal: PLoS One Date: 2015-08-21 Impact factor: 3.240
Authors: Tiago Jeronimo Dos Santos; Juan de Mata Donado Campos; Cristina Alexandra Fraga Medin; Jesús Argente; Fernando Rodríguez-Artalejo Journal: Syst Rev Date: 2019-11-04
Authors: Claudia Boettcher; Sascha R Tittel; Thomas Meissner; Bettina Gohlke; Rainer Stachow; Axel Dost; Sybille Wunderlich; Iris Lowak; Stefanie Lanzinger Journal: BMJ Open Diabetes Res Care Date: 2021-12
Authors: Marie Auzanneau; Joachim Rosenbauer; Werner Maier; Simone von Sengbusch; Johannes Hamann; Thomas Kapellen; Guido Freckmann; Silke Schmidt; Eggert Lilienthal; Reinhard W Holl Journal: J Diabetes Sci Technol Date: 2021-07-12